Related Experiment Videos
Does operative transluminal angioplasty extend the limits of coronary artery bypass surgery? A preliminary report
Insights
Operative transluminal angioplasty (OTA) effectively augments coronary bypass surgery for distal coronary artery disease. This study shows OTA improved outcomes in most patients, offering a valuable treatment option without significant complications.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Distal coronary artery disease poses challenges for traditional coronary bypass surgery.
- Limited runoff in primary coronary arteries and tandem lesions often complicate revascularization strategies.
Purpose of the Study:
- To evaluate the safety and efficacy of operative transluminal angioplasty (OTA) as an adjunct to coronary bypass surgery.
- To assess OTA's utility in treating complex coronary lesions, including distal and tandem stenoses.
Main Methods:
- Twenty-four patients underwent OTA, with 29 lesions dilated using 2-3 mm balloons.
- Dilatation involved direct visual monitoring during hand inflation.
- Repeat cardiac catheterization was performed postoperatively in eight patients.
Main Results:
- Successful dilatation was achieved in 25 of 29 lesions, enabling passage of larger probes.
- Seven of eight patients showed improvement upon repeat catheterization.
- No closures, extravasations, or aneurysms were observed; no perioperative infarctions or deaths occurred.
Conclusions:
- Operative transluminal angioplasty is a safe and effective adjunct to coronary bypass surgery for specific coronary artery disease scenarios.
- OTA expands revascularization options for distal, tandem, and branch coronary lesions, improving patient outcomes.
Abstract:
Distal coronary artery disease often reduces the feasibility and effectiveness of coronary bypass surgery to specific vessels. Operative transluminal angioplasty (OTA) is a valuable adjunct to coronary bypass surgery without significant sequelae. OTA should not be used to supplant coronary bypass; rather, if should be used to augment that procedure. We report our experience with 24 patients who underwent OTA. Twenty-nine lesions were dilated: 17 distal lesions in a primary coronary artery limiting runoff, six tandem lesions that would otherwise not warrant separate grafts, and six lesions in coronary branches and large enough to accept a bypass graft. Catheter dilatations were performed with 20-mm-long balloons inflated to an external diameter of 2-3 mm. Hand inflation monitored by direct vision for 10 second was used for dilatation. Severe stenosis prevented passage of the balloon across lesions in four cases. Stenoses in 25 lesions would not allow passage of a 0.5-1 mm probe before dilatation. After successful dilatation, passage of 1.5-2.0-mm probes was possible. Repeat cardiac catheterization was performed on eight patients 10 days to 4 months postoperatively. Seven patients improved, one did not improve, and there were no closures, extravasations or aneurysms. One hypercoagulable patient required reoperation for two early graft occlusions at 8 days. There were no perioperative infarctions or deaths.